Study of a single injection of RABI-767 for severe acute pancreatitis
Part of Digestive system clinical trials.
This trial tests a single injection of a new drug called RABI-767, given through a thin tube during an endoscopic ultrasound (EUS), to see if it can help people with severe acute pancreatitis. The drug is meant to reduce inflammation and prevent complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of acute pancreatitis (sudden, severe inflammation of the pancreas).
- Your pancreatitis must be predicted to become severe, based on your doctor's assessment.
- You should not have gotten significantly better since you were admitted to the hospital.
- You must be able to undergo an endoscopic ultrasound (EUS) procedure to receive the study drug.
- You must have a recent CT scan or MRI of your abdomen to check for certain exclusion criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medicine called SGC001 given as an injection to people with severe acute pancreatitis, a serious inflammation of the pancreas. The study aims to see if the drug is safe and helpful, and to gather early information on how it works.
This trial tests infliximab (an anti-inflammatory medicine) versus placebo to see if it improves outcomes in adults with newly diagnosed acute pancreatitis. It is designed for treatment to start within 36 hours of hospital admission.
This trial tests whether taking a probiotic called Bifidobacterium longum can help people with acute pancreatitis recover better. The study compares the probiotic against a placebo (a pill with no active ingredient) to see if it reduces inflammation and complications.
This early-phase trial is testing a new endoscopic (from inside the stomach) approach for pancreatic ductal adenocarcinoma that is locally advanced and cannot be removed with surgery. It may help some people who have already tried first chemotherapy and still have a tumor confined to the pancreas area (no spread).
This trial tests whether a pain-relieving epidural (numbing medicine placed near the spine) can help people with acute pancreatitis who are in the ICU because their organs are struggling. The goal is to see if this treatment improves recovery and reduces complications.
This trial is testing a new navigation system to help doctors see the pancreas during an endoscopic ultrasound (EUS) exam. The system may make it easier to spot lesions or other problems in the pancreas.
Hear when a new Acute Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.